$ATRC
AtriCure, Inc.

2020 Q2 Form 10-Q Financial Statement

#000132388520000044 Filed on July 29, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2 2019 Q1
Revenue $40.82M $58.91M $53.97M
YoY Change -30.7% 13.71% 14.84%
Cost Of Revenue $13.17M $15.01M $14.10M
YoY Change -12.28% 9.4% 12.84%
Gross Profit $27.65M $43.89M $39.87M
YoY Change -37.0% 15.27% 15.56%
Gross Profit Margin 67.74% 74.51% 73.88%
Selling, General & Admin $24.90M $37.93M $37.02M
YoY Change -34.34% 33.24% 6.13%
% of Gross Profit 90.05% 86.41% 92.84%
Research & Development $10.04M $9.804M $8.176M
YoY Change 2.37% 13.28% -9.73%
% of Gross Profit 36.29% 22.34% 20.51%
Depreciation & Amortization $2.460M $2.370M $1.744M
YoY Change 3.8% 7.73% -6.09%
% of Gross Profit 8.9% 5.4% 4.37%
Operating Expenses $34.94M $47.73M $45.19M
YoY Change -26.8% 28.58% 2.86%
Operating Profit -$7.285M -$3.839M -$5.320M
YoY Change 89.76% -500.73% -43.58%
Interest Expense $1.231M $879.0K $862.0K
YoY Change 40.05% -28.01% 5.12%
% of Operating Profit
Other Income/Expense, Net $29.00K -$9.000K -$107.0K
YoY Change -422.22% -94.0% -221.59%
Pretax Income -$8.224M -$4.091M -$5.569M
YoY Change 101.03% 1310.69% -44.78%
Income Tax $12.00K $10.00K $66.00K
% Of Pretax Income
Net Earnings -$8.236M -$4.101M -$5.635M
YoY Change 100.83% 1113.31% -44.4%
Net Earnings / Revenue -20.17% -6.96% -10.44%
Basic Earnings Per Share
Diluted Earnings Per Share -$197.8K -$109.8K -$152.5K
COMMON SHARES
Basic Shares Outstanding 40.07M 38.62M 38.61M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q2 2019 Q2 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $232.5M $90.80M $100.6M
YoY Change 156.06% 144.74% 179.44%
Cash & Equivalents $88.52M $25.25M $20.72M
Short-Term Investments $144.0M $65.60M $79.90M
Other Short-Term Assets $3.800M $3.300M $3.600M
YoY Change 15.15% 6.45% -5.26%
Inventory $32.81M $24.43M $24.12M
Prepaid Expenses
Receivables $22.89M $27.96M $26.66M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $292.0M $146.5M $155.0M
YoY Change 99.31% 68.81% 82.81%
LONG-TERM ASSETS
Property, Plant & Equipment $30.24M $28.10M $27.05M
YoY Change 7.62% -0.02% -5.09%
Goodwill $234.8M $105.3M $105.3M
YoY Change 123.05%
Intangibles $128.9M $48.29M $48.77M
YoY Change 166.96%
Long-Term Investments $15.30M $12.90M
YoY Change 18.6%
Other Assets $366.0K $473.0K $486.0K
YoY Change -22.62% -21.17% -30.57%
Total Long-Term Assets $412.2M $196.6M $183.3M
YoY Change 109.67% 6.85% -0.84%
TOTAL ASSETS
Total Short-Term Assets $292.0M $146.5M $155.0M
Total Long-Term Assets $412.2M $196.6M $183.3M
Total Assets $704.2M $343.1M $338.4M
YoY Change 105.24% 26.71% 25.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.47M $12.59M $10.38M
YoY Change -0.99% 29.81% -10.56%
Accrued Expenses $17.88M $19.89M $17.05M
YoY Change -10.06% 19.79% 20.93%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $800.0K $700.0K $600.0K
YoY Change 14.29%
Total Short-Term Liabilities $38.05M $39.43M $35.47M
YoY Change -3.5% 43.91% 31.84%
LONG-TERM LIABILITIES
Long-Term Debt $54.15M $33.89M $32.74M
YoY Change 59.81% -34.71% -36.92%
Other Long-Term Liabilities $182.2M $15.27M $17.52M
YoY Change 1093.24% -51.98% -53.64%
Total Long-Term Liabilities $236.4M $49.16M $50.26M
YoY Change 380.84% -41.27% -43.97%
TOTAL LIABILITIES
Total Short-Term Liabilities $38.05M $39.43M $35.47M
Total Long-Term Liabilities $236.4M $49.16M $50.26M
Total Liabilities $287.4M $101.6M $99.07M
YoY Change 182.92% -8.66% -15.04%
SHAREHOLDERS EQUITY
Retained Earnings -$306.8M -$256.7M -$252.6M
YoY Change 19.51%
Common Stock $723.8M $498.4M $492.2M
YoY Change 45.21%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $416.9M $241.5M $239.3M
YoY Change
Total Liabilities & Shareholders Equity $704.2M $343.1M $338.4M
YoY Change 105.24% 26.71% 25.46%

Cashflow Statement

Concept 2020 Q2 2019 Q2 2019 Q1
OPERATING ACTIVITIES
Net Income -$8.236M -$4.101M -$5.635M
YoY Change 100.83% 1113.31% -44.4%
Depreciation, Depletion And Amortization $2.460M $2.370M $1.744M
YoY Change 3.8% 7.73% -6.09%
Cash From Operating Activities -$11.55M $3.750M -$13.44M
YoY Change -408.0% -498.94% 42.44%
INVESTING ACTIVITIES
Capital Expenditures -$1.110M -$2.750M $1.709M
YoY Change -59.64% 99.28% -18.07%
Acquisitions
YoY Change
Other Investing Activities -$111.7M $1.810M $12.73M
YoY Change -6271.27% -121.7% -689.35%
Cash From Investing Activities -$112.8M -$930.0K $11.02M
YoY Change 12030.11% -90.44% -359.53%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 191.1M 1.700M -8.970M
YoY Change 11139.41% -50.29% -168.67%
NET CHANGE
Cash From Operating Activities -11.55M 3.750M -13.44M
Cash From Investing Activities -112.8M -930.0K 11.02M
Cash From Financing Activities 191.1M 1.700M -8.970M
Net Change In Cash 66.71M 4.520M -11.51M
YoY Change 1375.88% -162.34% 1768.67%
FREE CASH FLOW
Cash From Operating Activities -$11.55M $3.750M -$13.44M
Capital Expenditures -$1.110M -$2.750M $1.709M
Free Cash Flow -$10.44M $6.500M -$15.15M
YoY Change -260.62% 1377.27% 31.48%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
atrc Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Amounts Acquired During Acquisition Related Contingent Consideration
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAmountsAcquiredDuringAcquisitionRelatedContingentConsideration
atrc Proceeds From Capital Grant
ProceedsFromCapitalGrant
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Entity Central Index Key
EntityCentralIndexKey
0001323885
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-51470
dei Entity Registrant Name
EntityRegistrantName
AtriCure, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
34-1940305
dei Entity Address Address Line1
EntityAddressAddressLine1
7555 Innovation Way
dei Entity Address City Or Town
EntityAddressCityOrTown
Mason
dei Entity Address State Or Province
EntityAddressStateOrProvince
OH
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
45040
dei City Area Code
CityAreaCode
513
dei Local Phone Number
LocalPhoneNumber
755-4100
dei Security12b Title
Security12bTitle
Common Stock, $.001 par value
dei Trading Symbol
TradingSymbol
ATRC
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
44931713
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
88522000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28483000
CY2020Q2 us-gaap Short Term Investments
ShortTermInvestments
143976000
CY2019Q4 us-gaap Short Term Investments
ShortTermInvestments
53318000
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1096000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1124000
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
22892000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
28046000
CY2020Q2 us-gaap Inventory Net
InventoryNet
32809000
CY2019Q4 us-gaap Inventory Net
InventoryNet
29414000
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3835000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3899000
CY2020Q2 us-gaap Assets Current
AssetsCurrent
292034000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
143160000
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30236000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
32646000
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2573000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4032000
CY2020Q2 us-gaap Long Term Investments
LongTermInvestments
15339000
CY2019Q4 us-gaap Long Term Investments
LongTermInvestments
12675000
CY2020Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
128904000
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
129881000
CY2020Q2 us-gaap Goodwill
Goodwill
234781000
CY2019Q4 us-gaap Goodwill
Goodwill
234781000
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
366000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
705000
CY2020Q2 us-gaap Assets
Assets
704233000
CY2019Q4 us-gaap Assets
Assets
557880000
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
12467000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
14948000
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
17884000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
32750000
CY2020Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7701000
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2218000
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
38052000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
49916000
CY2020Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
54154000
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
59634000
CY2020Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
11377000
CY2019Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
11774000
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1581000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2796000
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
182207000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
186417000
CY2020Q2 us-gaap Liabilities
Liabilities
287371000
CY2019Q4 us-gaap Liabilities
Liabilities
310537000
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44939000
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44939000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39655000
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
39655000
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
45000
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
58906000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
94049000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
112872000
CY2020Q2 us-gaap Cost Of Revenue
CostOfRevenue
13170000
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-306841000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-282197000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
416862000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
247343000
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
704233000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
557880000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
40824000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
40000
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
723754000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
529658000
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-96000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-158000
CY2019Q2 us-gaap Cost Of Revenue
CostOfRevenue
15013000
us-gaap Cost Of Revenue
CostOfRevenue
27511000
us-gaap Cost Of Revenue
CostOfRevenue
29108000
CY2020Q2 us-gaap Gross Profit
GrossProfit
27654000
CY2019Q2 us-gaap Gross Profit
GrossProfit
43893000
us-gaap Gross Profit
GrossProfit
66538000
us-gaap Gross Profit
GrossProfit
83764000
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10036000
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9804000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21623000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17980000
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
24903000
CY2019Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
37928000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
67654000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
74943000
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
34939000
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
47732000
us-gaap Operating Expenses
OperatingExpenses
89277000
us-gaap Operating Expenses
OperatingExpenses
92923000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-7285000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3839000
us-gaap Operating Income Loss
OperatingIncomeLoss
-22739000
us-gaap Operating Income Loss
OperatingIncomeLoss
-9159000
CY2020Q2 us-gaap Interest Expense
InterestExpense
1231000
CY2019Q2 us-gaap Interest Expense
InterestExpense
879000
us-gaap Interest Expense
InterestExpense
2459000
us-gaap Interest Expense
InterestExpense
1741000
CY2020Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
263000
CY2019Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
636000
us-gaap Investment Income Interest
InvestmentIncomeInterest
668000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1356000
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
29000
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-94000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-116000
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8224000
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4091000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-24624000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9660000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12000
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
76000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-8236000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-4101000
us-gaap Net Income Loss
NetIncomeLoss
-24644000
us-gaap Net Income Loss
NetIncomeLoss
-9736000
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.20
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.61
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.26
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
41649000
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
37334000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
40160000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
37156000
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
174000
CY2019Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
17000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
111000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
83000
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
101000
CY2019Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
115000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-49000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-38000
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
275000
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
132000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
62000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
45000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-8236000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-4101000
us-gaap Net Income Loss
NetIncomeLoss
-24644000
us-gaap Net Income Loss
NetIncomeLoss
-9736000
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7961000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
227366000
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
188958000
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
8499000
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
275000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-8236000
CY2019Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
6225000
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
132000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-4101000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
241548000
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3969000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-24582000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9691000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
239292000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
416862000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
249381000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1858000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
45000
us-gaap Net Income Loss
NetIncomeLoss
-9736000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
241548000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
247343000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
188958000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
5143000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
62000
us-gaap Net Income Loss
NetIncomeLoss
-24644000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
416862000
us-gaap Net Income Loss
NetIncomeLoss
-24644000
us-gaap Net Income Loss
NetIncomeLoss
-9736000
us-gaap Share Based Compensation
ShareBasedCompensation
10577000
us-gaap Share Based Compensation
ShareBasedCompensation
8529000
us-gaap Depreciation
Depreciation
3925000
us-gaap Depreciation
Depreciation
3622000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
977000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
968000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
282000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
109000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-97000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-332000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-127000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
735000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-5046000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-3872000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5127000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-27635000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
656000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
404000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2859000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3402000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1966000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
7000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
710000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1970000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2407000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-14841000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-5845000
us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
-507000
us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
340000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9692000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
127069000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
31627000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
33732000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
46162000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2944000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4456000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
8000
atrc Proceeds From Capital Grant
ProceedsFromCapitalGrant
800000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-95481000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
10087000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
218000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
188958000
atrc Repayments Of Debt And Finance Lease Obligation
RepaymentsOfDebtAndFinanceLeaseObligation
280000
atrc Repayments Of Debt And Finance Lease Obligation
RepaymentsOfDebtAndFinanceLeaseObligation
303000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
4000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
300000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
6889000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2024000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
12323000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
8695000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
183240000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-7274000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-85000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-105000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
60039000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6984000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28483000
us-gaap Interest Paid Net
InterestPaidNet
2195000
us-gaap Interest Paid Net
InterestPaidNet
1746000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32231000
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
88522000
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25247000
us-gaap Income Taxes Paid
IncomeTaxesPaid
282000
us-gaap Income Taxes Paid
IncomeTaxesPaid
185000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
525000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
877000
us-gaap Nature Of Operations
NatureOfOperations
<span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Nature of the Business</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">—The “Company” or “AtriCure” consists of AtriCure, Inc. and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. The Company is </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">a </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management and sells its products to medical centers globally through its direct sales force and distributors.</span>
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-371000
CY2020Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
12771000
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
11126000
CY2020Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2226000
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1260000
CY2020Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
17812000
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
17028000
CY2020Q2 us-gaap Inventory Net
InventoryNet
32809000
CY2019Q4 us-gaap Inventory Net
InventoryNet
29414000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2770000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3592000
CY2019Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-286000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-158000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-199000
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-96000
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-154000
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-96000
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-154000
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6193000
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4375000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10577000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8529000
us-gaap Use Of Estimates
UseOfEstimates
<span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Use of Estimates</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">—The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expense during the reporting period. Actual results could differ from those estimates.</span>
CY2019Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
185157000
CY2018Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
18773000
CY2019 atrc Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Amounts Acquired During Acquisition Related Contingent Consideration
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAmountsAcquiredDuringAcquisitionRelatedContingentConsideration
171300000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
5046000
CY2019 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
4916000
CY2020Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
180111000
CY2019Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
185157000
CY2020Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
138012000
CY2020Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9108000
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
138012000
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8131000
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
488000
CY2019Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
484000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
977000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
968000
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
845000
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1511000
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
18000
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
18000
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
18000
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
173000
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2583000
CY2019Q4 us-gaap Goodwill
Goodwill
234781000
CY2018Q4 us-gaap Goodwill
Goodwill
105257000
CY2019 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
129524000
CY2020Q2 us-gaap Goodwill
Goodwill
234781000
CY2019Q4 us-gaap Goodwill
Goodwill
234781000
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7322000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6748000
CY2020Q2 atrc Sales Returns Allowance Trade
SalesReturnsAllowanceTrade
3921000
CY2019Q4 atrc Sales Returns Allowance Trade
SalesReturnsAllowanceTrade
3979000
CY2020Q2 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
3031000
CY2019Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
8734000
CY2020Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1728000
CY2019Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
10840000
CY2020Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
1136000
CY2019Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
1658000
CY2020Q2 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
495000
CY2019Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
732000
CY2020Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
251000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
59000
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
17884000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
32750000
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
14286000
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
17143000
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
17143000
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
11428000
CY2020Q2 atrc Cash Payment Obligations On Debt Current
CashPaymentObligationsOnDebtCurrent
5714000
CY2020Q2 atrc Cash Payment Obligations On Debt Noncurrent
CashPaymentObligationsOnDebtNoncurrent
54286000
CY2020Q2 us-gaap Long Term Debt
LongTermDebt
60000000
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y2M12D
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y6M
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0568
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0594
CY2020Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P10Y1M6D
CY2019Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P11Y
CY2020Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0693
CY2019Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0705
CY2020Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
340000
CY2019Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
159000
us-gaap Operating Lease Cost
OperatingLeaseCost
690000
us-gaap Operating Lease Cost
OperatingLeaseCost
318000
CY2020Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
263000
CY2019Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
250000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
526000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
500000
CY2020Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
212000
CY2019Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
219000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
428000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
440000
CY2020Q2 us-gaap Lease Cost
LeaseCost
475000
CY2019Q2 us-gaap Lease Cost
LeaseCost
469000
us-gaap Lease Cost
LeaseCost
954000
us-gaap Lease Cost
LeaseCost
940000
us-gaap Operating Lease Payments
OperatingLeasePayments
666000
us-gaap Operating Lease Payments
OperatingLeasePayments
355000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
428000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
440000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
280000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
303000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1691000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1884000
us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
2473000
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2573000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4032000
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1207000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1465000
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1581000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2796000
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
2788000
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
4261000
CY2020Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
780000
CY2019Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
753000
CY2020Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
11377000
CY2019Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
11774000
CY2020Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
12157000
CY2019Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
12527000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
554000
CY2020Q2 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
383000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1198000
CY2020Q2 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
1602000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
619000
CY2020Q2 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
1623000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
220000
CY2020Q2 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
1646000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
227000
CY2020Q2 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
1670000
CY2020Q2 atrc Lessee Operating Lease Liability Payments Thereafter
LesseeOperatingLeaseLiabilityPaymentsThereafter
234000
CY2020Q2 atrc Finance Lease Liability Payments Thereafter
FinanceLeaseLiabilityPaymentsThereafter
9799000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3052000
CY2020Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
16723000
CY2020Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
264000
CY2020Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
4566000
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
2788000
CY2020Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
12157000
CY2020Q2 us-gaap Royalty Expense
RoyaltyExpense
505000
CY2019Q2 us-gaap Royalty Expense
RoyaltyExpense
740000
us-gaap Royalty Expense
RoyaltyExpense
1181000
us-gaap Royalty Expense
RoyaltyExpense
1449000
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0015
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
112872000
CY2019Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0024
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0008
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0079
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
atrc Share Based Compensation Arrangement By Share Based Payment Award Number Of Share Based Incentive Plans
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfShareBasedIncentivePlans
2
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
40824000
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
58906000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
94049000
atrc Employee Stock Purchase Plan Offer Period
EmployeeStockPurchasePlanOfferPeriod
P6M
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Maximum Number Of Shares Per Employee
ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
3000
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6193000
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4375000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10577000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8529000

Files In Submission

Name View Source Status
0001323885-20-000044-index-headers.html Edgar Link pending
0001323885-20-000044-index.html Edgar Link pending
0001323885-20-000044.txt Edgar Link pending
0001323885-20-000044-xbrl.zip Edgar Link pending
atrc-20200630.xsd Edgar Link pending
atrc-20200630x10q.htm Edgar Link pending
atrc-20200630x10q_htm.xml Edgar Link completed
atrc-20200630xex31_1.htm Edgar Link pending
atrc-20200630xex31_2.htm Edgar Link pending
atrc-20200630xex32_1.htm Edgar Link pending
atrc-20200630xex32_2.htm Edgar Link pending
atrc-20200630_cal.xml Edgar Link unprocessable
atrc-20200630_def.xml Edgar Link unprocessable
atrc-20200630_lab.xml Edgar Link unprocessable
atrc-20200630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending